Kathelijn S. Versteeg
Papers
1
Total Citations
47
H-Index
1
About
Kathelijn S. Versteeg is a leading clinical researcher in surgical oncology, with a primary focus on optimizing local treatments for colorectal liver metastases (CRLM). Her work centers on the critical comparison between surgical resection and thermal ablation, aiming to define the safest and most effective approach for patients with small-size liver tumors. Her major contribution is her role in the landmark COLLISION trial, an international, multicenter, phase III randomized controlled study that directly compares surgery versus thermal ablation for small-size CRLM. This pivotal research challenges long-standing clinical paradigms by providing high-level evidence on outcomes, safety profiles, and recovery times. With her most cited paper from 2024 already garnering 47 citations, Versteeg’s work is rapidly shaping modern treatment guidelines. By demonstrating that thermal ablation may offer superior safety, lower costs, and shorter hospital stays while rivaling the efficacy of surgery, she is helping to shift the standard of care toward less invasive, patient-friendly options. Her research is essential reading for oncologists and surgeons seeking to balance curative intent with quality of life.
Research Focus
Key Achievements
Top Papers
- 1